ICN Pharmaceuticals Appoints Bolivia RPCV Gelbard to Head International Efforts
ICN Pharmaceuticals Appoints Gelbard to Head International Efforts
COSTA MESA, Calif., March 26 /PRNewswire/ -- ICN Pharmaceuticals, Inc (NYSE: ICN - news), a research-based global pharmaceuticals company, today announced the appointment of former Ambassador Robert Gelbard as Senior Vice President for International Affairs and Government Relations. Gelbard will represent ICN in dealings with foreign governments and organizations and with United States government agencies and industry trade groups.
Ambassador Gelbard has held numerous senior positions with the State Department, most recently serving as United States Ambassador to Indonesia and East Timor. He served as Special Representative of the President and the Secretary of State for the Balkans from 1997 until 1999. In that position, he was responsible for all aspects of U.S. government policy development and civilian implementation in the Balkans, including particularly Bosnia-Herzegovina, Serbia and Montenegro, and Croatia. Other major positions Gelbard has held include: United States Ambassador to Bolivia; Assistant Secretary of State for International Narcotics and Law Enforcement Affairs; and Principal Deputy Assistant Secretary of State for Inter-American Affairs. Upon his retirement from the State Department in January 2002, Gelbard was personally awarded the Secretary's Distinguished Service Award, the State Department's highest honor, from Secretary of State Colin Powell.
Ambassador Gelbard joined the Foreign Service in 1967 after serving in the Peace Corps in Bolivia from 1964 to 1966. He graduated from Colby College in 1964 with a B.A. in history and in 1979 received an MPA in economics from Harvard University. He was awarded an honorary law degree from Villanova University in 1998. For his service as Ambassador to Bolivia, Gelbard was awarded that country's highest honor for foreign citizens, ``Condor of the Andes, Order of the Grand Cross''. He is married to Alene Gelbard and has one daughter, Alexandra.
Regarding Ambassador Gelbard's appointment to ICN, Chairman and CEO Milan Panic stated, ``I am proud to have Ambassador Gelbard join ICN Pharmaceuticals. He is widely recognized as a leader in international affairs at the highest level. His experience in Washington affairs also will help ICN enhance its rightful place in the pharmaceutical industry.''
ICN is an innovative, research-based company that manufactures, markets and distributes a broad range of pharmaceuticals, including anti-virals, dermatologicals and oncology products. ICN's expanding platform in the cosmetic dermatology category includes the leading post-procedure moisturizer, Kinerase® (N6-Furfuryladeine) and its established GlyDerm® line of cosmeceutical skin care products. ICN also markets Efudex® (Fluorouracil), for the treatment of actinic keratosis.
Additional information is available on the Company's website at http://www.icnpharm.com .
